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Abstract
Background: Chorionic carcinoma is a highly malignant gynecological tumor, frequently originating from
trophoblastic cells in the uterus after fertilization. Early erosion releases cancerous cells into the circulation to invade
surrounding organs without primary symptoms and signs.
Methods: One case of choriocarcinoma sellar region metastasis was analyzed, utilizing clinical data, MRI and
pathological examinations, and clinical characteristics were summarized.
Results: Choriocarcinoma sellar region metastasis is easily misdiagnosed. We examined the literature and original
resources to summarize the clinical characteristics of choriocarcinoma sellar region metastasis and discuss available
therapies.
Conclusion: This case study of a metastasis of choriocarcinoma to the sellar region provides important new data
on the incidence and pathology of this rare disease.
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Background
Chorionic carcinoma is a highly malignant gynecological
tumor, frequently originating from trophoblastic cells in
the uterus after fertilization. Early erosion releases cancer-
ous cells into the circulation to invade surrounding organs
without primary symptoms and signs [1]. In the event of
late brain metastases when disseminated tumor cells enter
cerebrospinal fluid, few patients survive more than a year.
Primary chorionic carcinoma is associated with lung me-
tastasis in about one-third of cases [2], and the incidence
of brain metastasis is 6.3–22.5 % [3]. Metastatic lesions in
the cerebral hemisphere and sellar area are rare and diffi-
cult to distinguish by imaging from more common sellar
area tumors such as tuberculum sella meningiomas and
large invasive pituitary adenomas. Here we report one
case of chorionic carcinoma brain metastasis to the sellar
area and summarize the recent literature.
Methods
One case of choriocarcinoma sellar region metas-
tasis was analyzed, utilizing clinical data, MRI and
pathological examinations, and clinical characteristics
were summarized.
Results
Choriocarcinoma sellar region metastasis is easily misdiag-
nosed. We examined the literature and original resources
to summarize the clinical characteristics of choriocarcin-
oma sellar region metastasis and discuss available therapies.
Case presentation
History: A 24 year old female was admitted into the
gynecology department with a history of menopause and
vaginal bleeding in the preceding two months and abdom-
inal pain for one day. Her last menstrual period was four
months prior and abnormal vaginal bleeding had occurred
twice in the most recent three months. During
hospitalization, the patient reported headaches and blurred
vision. Upon physical examination, the patient was 165 cm
in height and weighed 45 kg. Blood pressure was
100/68 mmHg, pulse 58 beats/min. The patient reported
loss of binocular eyesight acuity, bilateral temporal hemi-
anopsia, left abdominal tenderness and painful bounce.
Laboratory data are shown in Table 1. In particular, pro-
lactin (PRL) and blood β-human chorionic gonadotropin
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(β-HCG) were abnormally high. Preliminary diagnosis was
either chorionic carcinoma or pituitary adenoma. Ultra-
sound (Fig. 1) examination showed pelvic cavity fluid ac-
cumulation and normal double ovaries. MRI shows
diaphragma sella is pushed up, and sella bottom shows
bone absorption and destruction. Diagnosis from MRI
(Fig. 2) examination indicated possible pituitary adenoma.
Table 1 Patient laboratory data
Parameter Laboratory data Normal range Unit
FT3 2.17 3.10–6.80 pmol/L
FT4 7.23 12.00–22.00 pmol/L
T3 0.96 1.30–3.10 nmol/L
T4 55.24 66.00–181.00 nmol/L
TSH 1.290 0.270–4.200 mIU/L
PRL 1806.00 102–496 mIU/l
LH <0.10 2.4–12.6 mIU/l
FSH 0.16 3.5–12.5 IU/l
GH 0.676 0.1260–9.8800 ng/ml
ACTH 7.290 7.200–63.300 pg/ml
PROG 0.45 0.6–4.7 nmol/l
White blood cells 4.31 3.50–9.50 109/L
Red blood cells 3.42 3.80–5.10 1012/L
Hemoglobin 102 115–150 g/L
Na+ 131.67 137–147 mmol/L
K+ 3.52 3.50–5.30 mmol/L
Cl 93.59 96.00–110.00 mmol/L
Glucose 3.73 3.9–6.1 mmol/L
U-SG 1.01 1.005–1.030
β-HCG Pre-operation 15d Pre-operation 1d Post-operation 3d Post-operation 30d Post-operation 60d
Normal range
(0–5.3 IU/ml)
40636.0 499311.0 3957.0 56626.0 88729.0
Fig. 1 Patient Ultrasound. Pelvic cavity fluid accumulation and
normal double ovaries
Fig. 2 Patient MRI. a, b MRI shows enlargement of the sella.
Anteroposterior diameter is about 1.5 cm, with mixed visible T1WI
and T2WI signals in the sellar area. Scope is 2.5 cm × 2.3 cm × 2.0 cm.
c, d Enhanced mass is relatively low. Diaphragma sella is pushed up,
and sella bottom shows bone absorption and destruction. Bilateral
cavernous sinus boundary is not clear
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Physicians concluded that the serious decline in vision
was the result of rapid sellar area tumor growth and trans-
ferred the patient to our neurosurgery department. Sella
area tumor resection was performed by the supraorbital
eyebrow keyhole approach. The bone flap was 3 × 2 cm.
The frontal lobe was pull open to find a solid white
tumor of tough disposition. The blood supply was ex-
tremely rich. The lesion was subtotally removed. The
volume of the tumor resection was 2 cm3. The optic
chiasm and optic nerve decompressed during the oper-
ation. Surgery proceeded smoothly and bilateral vision
improved after operation but declined again after one
month. An MRI scan verified tumor recurrence and the
blood β-HCG level again increased. HE stain showed
obviously regression abnormity tumor cells and immu-
nostain revealed HCG expression in tumor cells. Patho-
logical diagnosis was chorionic epithelioma (Fig. 3).
Discussion
Germ cell tumors account for 0.2–1.7 % of intracranial
tumors. Six subtypes of tumor have been described, in-
cluding chorionic carcinoma, embryonal carcinoma and
mixed germ cell tumors [3]. The most common germ
cell tumors often occur in the pineal gland area (35.3 %)
and sellar area (17.6 %) [4]. However, chorionic carcin-
oma cerebral metastases are rare, particularly in the
sellar region. Two cases of chorionic carcinoma metasta-
sis to the sellar area were found in two references
through the Embase system. One case was reported by
Huashan hospital [5], the other was reported by Liu in
Taiwan [6]. Both cases involved children. To our
knowledge, our report is the first case of chorionic car-
cinoma brain metastasis in a woman of childbearing age.
The patient in the present case had no previous his-
tory of pregnancy, but did report abnormal vaginal
bleeding on two occasions before admission. Diagnosis
was missed because no primary lesions were detected in
ultrasound. Kyritsis et al. [7] reviewed cases of unknown
primary brain metastases which included a few examples
of chorionic carcinoma, based on imaging features of
brain metastatic tumors, clinical manifestations or diag-
nosis of malignant brain tumor by biopsy. However, in
these cases, the primary site of metastasis was not deter-
mined from patient history, physical examination or la-
boratory testing, and chorionic carcinoma accounted for
only 3–5 % of solid tumors.
The clinical characteristics of choriocarcinoma metasta-
sis to the sellar area are summarized as follows: 1. History
of sexual activity in women of childbearing age and recent
irregular vaginal bleeding; 2. Increasing urine output and
aggravation of hyponatremia; 3. History of visual impair-
ment and symptoms of high cranial pressure; 4. Endocrine
disorders, pituitary function impairment, growth hormone
deficiency and sexual developmental disorders; 5. Con-
tinuing increase in β-HCG after gynecological operation.
Higher β-HCG levels can promote chorionic epithelial
carcinomas or mixed germ cell tumors. Levels of β-HCG
>1000 mIU/ml (normal range 0–5.3 IU/ml) are almost al-
ways associated with chorionic carcinoma or choriocarci-
nomic cell types in mixed germ cell tumors; 6. Intracranial
germ cell tumors easily metastasize through cerebrospinal
fluid. Tumor cells can be detected in the cerebrospinal
fluid of some patients, which is of great diagnostic signifi-
cance, although the clinical detection rate is low. CT scan
of chorionic carcinoma shows slightly higher density
shadows accompanied by calcification and bleeding; 7.
Slightly higher or mixed signals in MRI T1W1 scans
occur because of different subacute periods of bleeding
in the tumor;8. Microscopic pathological examination
shows areas of poorly differentiated trophoblastic cells,
hemorrhage and necrosis. Chorionic carcinoma can be
definitely diagnosed if no villi structure is found with an
accuracy rate of 70–80 %.
Chemotherapy is currently the preferred treatment for
chorionic carcinoma. Radiotherapy and surgery may be
used as complementary treatments. Surgery for brain me-
tastases must be determined according to the situation.
Minimally invasive surgery in the sellar area is feasible by
nasal butterfly. A clear diagnosis from a pathological
examination of intraoperative biopsy tissue must be ob-
tained before deciding upon treatment methods. Chori-
onic carcinoma is a malignant tumor which occurs in the
gonads and contains Sertoli cell components sensitive to
chemotherapy. Unfortunately, because of the blood brain
barrier, it is difficult to achieve concentrations of
Fig. 3 Pathology of sellar region. a HE stain (×100) shows large area
of necrosis with a few variant cells. b HE stain (×400) obviously
regression abnormity tumor cells. c HCG immunostain (×400)
showing HCG expression in tumor cells. d CK immunostain (×400)
showing CK expression in tumor cells. Immunohistochemical analysis:
CK-P(+), PLAP(−), HCG(+), AFP(−) CD30(−), CD3(focal+), CD20(Individual
cells +), Vimentin(−), Syn(−), CgA(−), GFAP(−), CD117(−), PRL(−), GH(−),
ACTH(−), LH(−), FSH(−), TSH(−); Ki-67 positive cells: 35 %
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chemotherapeutic agents in the brain from systemic
chemotherapy which are sufficient to suppress tumor
growth. Therefore, radiotherapy using whole brain irradi-
ation should be combined with chemotherapy. Radiation
therapy is effective in most of cases and can significantly
increase survival time.
Conclusion
Chorionic carcinoma metastases to the sellar area are not
detected in early age. Disease progression produces vision
loss and reduced pituitary function, and often results in
serious nerve dysfunction because of misdiagnosis. This
review and case study have been written to summarize
our current understanding of the incidence and clinical
characteristics of chorionic carcinoma metastases to the
sellar area, and will hopefully give impetus to further study
this serious disease.
Abbreviations
MRI: Magnetic Resonance Imaging; FT3: Free triiodothyronine; FT4: Free
thyroxine; T3: Triiodothyronine; T4: Thyroxine; TSH: Thyroid-stimulating
hormone; PRL: Prolactin; LH: Luteinizing hormone; FSH: Follicle-stimulating
hormone; GH: Growth hormone; ACTH: Adrenocorticotropin;
PROG: Progesterone; SG: Specific gravity of urine; HCG: Human chorionic
gonadotropin; CT: Computed tomography; HE: Hematoxylin and eosin stain;
CK: Creatine kinase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JS carried out the molecular genetic studies and clinical research,
participated in the drafted the manuscript. YH conceived the study,
participated in its design and coordination, and helped draft the manuscript.
Both authors have read and approved the final manuscript.
Acknowledgements
We thank Dr. Tian Xinhua for helpful comments and suggestions.
Received: 3 June 2015 Accepted: 2 October 2015
References
1. Tabouret E, Bauchet L, Carpentier AF. Brain metastases epidemiology and
biology. Bull Cancer. 2013;100(1):57–62.
2. Sievers EL, Berger M, Geyer JR. Long-term survival of a patient with primary
sellar choriocarcinoma with pulmonary metastases: a case report. Med
Pediatr Oncol. 1996;26(4):293–5.
3. Johnson RH, Chien FL, Bleyer A. Incidence of breast cancer with distant
involvement among women in the United States, 1976 to 2009. JAMA.
2013;309(8):800–5.
4. Gao Y, Jiang J, Liu Q. Clinicopathological and immunohistochemical
features of primary central nervous system germ cell tumors: a 24-years
experience. Int J Clin Exp Pathol. 2014;7(10):6965–72.
5. Chen L, Zou X, Wang Y, Mao Y, Zhou L. Central nervous system tumors:
a single center pathology review of 34,140 cases over 60 years. BMC Clinical
Pathology. 2013;13:14.
6. Ho DM, Liu HC. Primary intracranial germ cell tumor. Pathologic study of 51
patients. Cancer. 1992;70(6):1577–84.
7. Kyritsis AP, Markoula S, Levin VA. A systematic approach to the
management of patients with brain metastases of known or unknown
primary site. Cancer Chemother Pharmacol. 2012;69(1):1–13.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sun and Huang Chinese Neurosurgical Journal  (2015) 1:16 Page 4 of 4
